ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,702Medicare Part D Prescriptions Filled, Including Refills

Rank: 65 out of 6969

$609K Total Retail Price of All Prescriptions

Rank: 390 out of 6969

848 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

26% of this provider’s 848 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 18,668 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$28 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LEVOTHYROXINE SODIUM 1,366 1,237 1 5
OMEPRAZOLE 1,209 1,046 2 6
SIMVASTATIN 1,165 1,017 3 1
METFORMIN HCL 1,003 847 4 7
LOSARTAN POTASSIUM 925 800 5 12
HYDROCODONE-ACETAMINOPHEN 718 521 S3 6 3
AMLODIPINE BESYLATE 646 613 7 4
DOXAZOSIN MESYLATE 511 472 8 74
ENALAPRIL MALEATE 451 342 9 56
ATENOLOL 429 403 10 9
FUROSEMIDE 399 366 11 10
GABAPENTIN 387 338 12 17
METOPROLOL TARTRATE 380 331 13 13
LISINOPRIL 380 333 13 2
ZOLPIDEM TARTRATE 373 325 15 16
LOSARTAN-HYDROCHLOROTHIAZIDE 350 319 16 53
LORAZEPAM 323 292 17 186
TAMSULOSIN HCL 322 303 18 23
ALENDRONATE SODIUM 317 293 19 14
LOVASTATIN 291 291 20 15
CEPHALEXIN 276 226 21 96
MELOXICAM 272 253 22 36
GLIPIZIDE 269 175 23 21
CITALOPRAM HBR 231 196 24 34
NIFEDIAC CC 227 210 10 25 248
HYDROCHLOROTHIAZIDE 225 195 26 8
BENAZEPRIL HCL 214 168 27 18
PAROXETINE HCL 199 171 28 65
FINASTERIDE 196 184 29 80
GLIMEPIRIDE 192 176 30 44
GEMFIBROZIL 188 146 31 85
DONEPEZIL HCL 186 186 32 32
POTASSIUM CHLORIDE 182 175 33 30
AZITHROMYCIN 181 145 34 42
NIFEDIPINE ER 180 171 35 95
CIPROFLOXACIN HCL 159 130 36 64
LANTUS 159 111 36 50
GLYBURIDE 155 151 R 38 54
IBUPROFEN 154 123 39 29
NAPROXEN 153 121 40 62
CARVEDILOL 138 122 41 25
TRIAMTERENE-HCTZ 117 98 42 58
MIRTAZAPINE 116 103 43 76
DIOVAN 114 89 44 26
FLUTICASONE PROPIONATE 110 86 45 24
ALPRAZOLAM 105 105 46 172
PANTOPRAZOLE SODIUM 100 90 47 31
PROAIR HFA 98 75 48 33
MECLIZINE HCL 98 90 48 100
JANUVIA 95 87 50 41
CLOPIDOGREL 89 74 51 48
CLONIDINE HCL 88 79 52 59
HYDROCORTISONE 83 68 53 218
INSULIN SYRINGE 83 72 53 60
HYDROXYZINE HCL 83 78 R 53 159
POLYETHYLENE GLYCOL 3350 76 67 56 127
KETOCONAZOLE 75 67 57 185
FAMOTIDINE 74 58 58 37
PLAVIX 72 63 59 68
ADVAIR DISKUS 70 48 60 45
CLOTRIMAZOLE-BETAMETHASONE 70 51 60 182
LANTUS SOLOSTAR 70 62 60 154
PRISTIQ ER 68 42 63 370
PREMARIN 68 66 R 63 156
DETROL LA 66 43 65 223
ATORVASTATIN CALCIUM 62 32 66 11
KLOR-CON 10 61 61 67 160
ISOSORBIDE MONONITRATE ER 60 59 68 81
TERAZOSIN HCL 59 55 69 49
ZETIA 59 46 69 98
TEKTURNA 58 58 71 295
WARFARIN SODIUM 58 49 71 20
NAMENDA 56 56 73 51
CAPTOPRIL 56 56 73 226
PEN NEEDLE 56 38 73 196
NEOMYCIN-POLYMYXIN-DEXAMETH 55 46 76 416
ACTOS 53 36 77 61
DIOVAN HCT 52 52 78 57
DILTIAZEM 24HR ER 51 41 79 183
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 26, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.